ctrl K

Price Alert

Yumanity Therapeutics Inc... (YMTX)

NASDAQ: YMTX · Real-Time Price · USD

1.89

0.15 (8.62%)

At close: Dec 19, 2022, 6:00 AM

Yumanity Therapeutics Revenue Breakdown

Period Ending	Jun 30, 2023	Mar 31, 2023
Collaboration revenue Revenue	161K	281K
Collaboration revenue Revenue Growth	-42.70%	n/a
Grant Revenue	n/a	n/a
Grant Revenue Growth	n/a	n/a
License Revenue	5M	n/a
License Revenue Growth	n/a	n/a

Operating Expense Breakdown

Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Sep 30, 2020
Selling, General, and Administrative Revenue	1.4M	172K	1.16M	1.59M	3.68M	2.71M	2.08M	3.43M	3.92M	3.22M	2.05M	1.82M	1.61M	3.78M	3.22M	3.44M	4.8M	4.18M
Selling, General, and Administrative Revenue Growth	+715.70%	-85.13%	-27.10%	-56.88%	+35.99%	+30.28%	-39.46%	-12.56%	+22.01%	+57.18%	+12.11%	+13.42%	-57.45%	+17.53%	-6.51%	-28.39%	+15.06%	n/a
Research and Development Revenue	617K	99K	898K	1M	2.73M	1.56M	1.91M	2.71M	2.84M	24.28M	2.6M	3.88M	4.02M	5.56M	6.49M	7.15M	6.58M	1.24M
Research and Development Revenue Growth	+523.23%	-88.98%	-10.29%	-63.28%	+74.63%	-18.23%	-29.56%	-4.68%	-88.29%	+832.09%	-32.84%	-3.58%	-27.68%	-14.23%	-9.31%	+8.71%	+430.56%	n/a